BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+24.79%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.9B
AUM Growth
+$1.9B
Cap. Flow
+$40.6M
Cap. Flow %
2.14%
Top 10 Hldgs %
50.01%
Holding
78
New
5
Increased
7
Reduced
10
Closed
7

Top Buys

1
AXSM icon
Axsome Therapeutics
AXSM
$30.9M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$20.2M
3
GERN icon
Geron
GERN
$19.6M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$17.7M
5
VKTX icon
Viking Therapeutics
VKTX
$14.1M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$22.1M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$20.7M
3
BPMC
Blueprint Medicines
BPMC
$18.1M
4
VERU icon
Veru
VERU
$11.4M
5
ALT icon
Altimmune
ALT
$6.39M

Sector Composition

1 Healthcare 99.67%
2 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$209M 11% 1,897,500 +183,500 +11% +$20.2M
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$110M 5.8% 500,000 – –
CYTK icon
3
Cytokinetics
CYTK
$4.23B
$96.2M 5.07% 2,100,000 – –
RVMD icon
4
Revolution Medicines
RVMD
$7.1B
$94.9M 5% 3,984,264 – –
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$90.6M 4.78% 2,000,000 – –
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$89M 4.69% 3,421,541 – –
APLS icon
7
Apellis Pharmaceuticals
APLS
$3.48B
$81.5M 4.3% 1,576,000 +272,300 +21% +$14.1M
AMLX icon
8
Amylyx Pharmaceuticals
AMLX
$836M
$77M 4.06% 2,084,000 – –
TNGX icon
9
Tango Therapeutics
TNGX
$747M
$51.6M 2.72% 7,123,642 +252,000 +4% +$1.83M
TYRA icon
10
Tyra Biosciences
TYRA
$675M
$49M 2.58% 6,448,359 – –
RETA
11
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$46.7M 2.46% 1,230,004 -8,996 -0.7% -$342K
AKRO icon
12
Akero Therapeutics
AKRO
$3.74B
$45.6M 2.4% 831,495 – –
ITOS icon
13
iTeos Therapeutics
ITOS
$449M
$42.1M 2.22% 2,154,058 – –
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$41.7M 2.2% 1,094,000 – –
ANAB icon
15
AnaptysBio
ANAB
$569M
$40.3M 2.12% 1,300,000 – –
IDYA icon
16
IDEAYA Biosciences
IDYA
$2.15B
$40M 2.11% 2,202,812 – –
CNTA
17
Centessa Pharmaceuticals
CNTA
$2.25B
$38.8M 2.04% 1,251,137 – –
NUVL icon
18
Nuvalent
NUVL
$5.52B
$36M 1.9% 1,210,192 – –
RLAY icon
19
Relay Therapeutics
RLAY
$619M
$32.4M 1.71% 2,169,132 – –
AXSM icon
20
Axsome Therapeutics
AXSM
$6.05B
$30.9M 1.63% +400,000 New +$30.9M
RCUS icon
21
Arcus Biosciences
RCUS
$1.13B
$29.6M 1.56% 1,432,200 – –
MRUS icon
22
Merus
MRUS
$4.98B
$29.4M 1.55% 1,900,000 – –
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$354M
$28.7M 1.51% 1,466,051 – –
FOLD icon
24
Amicus Therapeutics
FOLD
$2.34B
$28.4M 1.5% 2,325,000 – –
VTYX icon
25
Ventyx Biosciences
VTYX
$171M
$27.9M 1.47% 850,000 – –
1
2 3 4